Australia's Proteomics climbs on US patent for endometriosis test

Proteomics International Laboratories

08/07/2026 04:24

** Shares of Proteomics International Laboratories PIQ.AX climb as much as 41.9% to A$0.22, their biggest intraday pct rise since early-April 2020 
** The medical technology firm announces the United States Patent and Trademark Office (USPTO) has granted a new patent for the PromarkerEndo proprietary blood test for the diagnosis of endometriosis
** Adds that patent supports commercialisation efforts and underpins the commercialisation pathway, enabling future partnerships and licensing opportunities
** About 1.4 million shares change hands, 2.6 times the 30-day avg
** Proteomics stock down ~72%, YTD
     

 (Reporting by Anjali Singh in Bengaluru)
 ((anjali.singh2@thomsonreuters.com;))